FDA grants full approval to Paxlovid to treat COVID-19
May 25, 2023
Paxlovid has been taken by older adults and others at high risk for severe COVID-19 under an emergency use approval.
Half of American workers support COVID-19 vaccination, mask mandates in workplace
Aug 27, 2021
The poll was conducted before the FDA granted full approval to the Pfizer COVID-19 vaccine.
US sets up $300 million database for Alzheimer’s disease research
Apr 05, 2023
In creating the database, the goal is to provide something that can “improve applicability and generalizability of findings.”
COVID-19 vaccine patent rules reconsidered by World Trade Organization
Jun 08, 2021
The idea is backed by more than 60 countries, including the United States.
Cranberry supplements may aid memory in older adults
May 24, 2022
Improvement in neural functioning also was seen during a 12-week intervention.
FDA to prioritize full approval for Pfizer COVID-19 vaccine
Jul 16, 2021
Full approval could help boost vaccination efforts in the United States.
Road traffic, railway noise linked to increased dementia risk
Sep 10, 2021
The general pattern showed higher hazard ratios with higher noise exposure, with levelling off or a decline at higher noise levels.
Medicare will cover new class of Alzheimer’s drugs if fully approved by FDA, with limits
Jun 02, 2023
Drug makers also will have to gather and keep data in a registry showing how the drugs are working in the real world.
European Union passes U.S. in COVID-19 vaccination rates
Aug 09, 2021
Rates of people in the 27-member EU with at least one dose have climbed from less than 4% in mid-February to 60%, whereas rates in the United States rose from nearly 12% to less than 58%.
Most COVID-19-related EUAs not supported by high-quality evidence
Dec 30, 2021
For drugs and vaccines, the emergency use authorizations were mostly supported by randomized clinical trials.